SOLUBLE C-ERBB-2 FRAGMENT IN SERUM CORRELATES WITH DISEASE STAGE AND PREDICTS FOR SHORTENED SURVIVAL IN PATIENTS WITH EARLY-STAGE AND ADVANCED BREAST-CANCER

被引：80

作者：

KANDL, H ^{[1
]}

SEYMOUR, L ^{[1
]}

BEZWODA, WR ^{[1
]}

机构：

[1] UNIV WITWATERSRAND,SCH MED,DEPT MED,DIV CLI HAEMATOL & MED ONCOL,JOHANNESBURG 2193,SOUTH AFRICA

来源：

BRITISH JOURNAL OF CANCER | 1994年 / 70卷 / 04期

关键词：

D O I：

10.1038/bjc.1994.387

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Seventy-nine patients with advanced breast cancer were tested for the presence, in serum, of a 110 kDa soluble, c-erbB-2 fragment. Thirty-nine patients were seropositive. There was no correlation between seropositivity and menopausal status, or with oestrogen status. In addition, no correlation could be found between tissue c-erbB-2 immunostaining for the external domain of the c-erbB-2 receptor and the presence of soluble c-erbB-2 in serum. The presence of serum soluble c-erbB-2, however, had a significant impact on survival of patients with advanced disease, suggesting that this test may become a useful independent prognostic indicator.

引用

页码：739 / 742

页数：4

共 23 条

[11] INVITRO AND INVIVO RELEASE OF SOLUBLE ERBB-2 PROTEIN FROM HUMAN CARCINOMA-CELLS [J].

MORI, S ;

MORI, Y ;

MUKAIYAMA, T ;

YAMADA, Y ;

SONOBE, Y ;

MATSUSHITA, H ;

SAKAMOTO, G ;

AKIYAMA, T ;

OGAWA, M ;

SHIRAISHI, M ;

TOYOSHIMA, K ;

YAMAMOTO, T .

JAPANESE JOURNAL OF CANCER RESEARCH, 1990, 81 (05) :489-494

[12]

PATERSON MC, 1991, CANCER RES, V51, P556

[13]

Perez Cynthia, 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P97

[14] NUCLEAR AND FLOW CYTOMETRIC CHARACTERISTICS ASSOCIATED WITH OVEREXPRESSION OF THE C-ERBB-2 ONCOPROTEIN IN BREAST-CARCINOMA [J].

POLLER, DN ;

GALEA, M ;

PEARSON, D ;

BELL, J ;

GULLICK, WJ ;

ELSTON, CW ;

BLAMEY, RW ;

ELLIS, IO .

BREAST CANCER RESEARCH AND TREATMENT, 1991, 20 (01) :3-10

[15] THE SOLUBLE INTERLEUKIN-2 RECEPTOR - BIOLOGY, FUNCTION, AND CLINICAL-APPLICATION [J].

RUBIN, LA ;

NELSON, DL .

ANNALS OF INTERNAL MEDICINE, 1990, 113 (08) :619-627

[16] C-ERBB-2 POSITIVE BREAST-TUMORS BEHAVE MORE AGGRESSIVELY IN THE 1ST YEARS AFTER DIAGNOSIS [J].

SCHROETER, CA ;

DEPOTTER, CR ;

RATHSMANN, K ;

WILLIGHAGEN, RGJ ;

GREEP, JC .

BRITISH JOURNAL OF CANCER, 1992, 66 (04) :728-734

[17] HER-2 NEU ONCOGENE PROTEIN AND PROGNOSIS IN BREAST-CANCER [J].

TANDON, AK ;

CLARK, GM ;

CHAMNESS, GC ;

ULLRICH, A ;

MCGUIRE, WL .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (08) :1120-1128

[18]

TERAMOTO Y, 1991, P AN AM ASS CANCER R, P243

[19] PROGNOSTIC-SIGNIFICANCE OF HER-2 ONCOPROTEIN EXPRESSION IN BREAST-CANCER - A 30-YEAR FOLLOW-UP [J].

TOIKKANEN, S ;

HELIN, H ;

ISOLA, J ;

JOENSUU, H .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (07) :1044-1048

[20] NEU-PROTEIN OVEREXPRESSION IN BREAST-CANCER - ASSOCIATION WITH COMEDO-TYPE DUCTAL CARCINOMA INSITU AND LIMITED PROGNOSTIC VALUE IN STAGE-II BREAST-CANCER [J].

VANDEVIJVER, MJ ;

PETERSE, JL ;

MOOI, WJ ;

WISMAN, P ;

LOMANS, J ;

DALESIO, O ;

NUSSE, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (19) :1239-1245

← 1 2 3 →